Crinetics Pharmaceuticals Reaches New High, Investors Wonder: Is It Time to Buy?
☀️Trending News Crinetics Pharmaceuticals ($NASDAQ:CRNX), a biotechnology company focused on developing treatments for rare endocrine diseases, has been making headlines [...]
State Street Corp bolsters investment portfolio with strategic acquisition of Crinetics Pharmaceuticals shares
☀️Trending News State Street Corp, a leading financial services and investment management company, announced on September 30, 2024 that it [...]
Crinetics Pharmaceuticals Inc Stock Heating Up on Tuesday?
🌥️Trending News Crinetics Pharmaceuticals ($NASDAQ:CRNX) Inc is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics [...]
CRINETICS PHARMACEUTICALS Reports 23.9% Revenue Decline for Third Quarter Ending September 30 2023
🌥️Earnings Overview On November 7 2023, CRINETICS PHARMACEUTICALS ($NASDAQ:CRNX) revealed total revenue of USD 0.3 million for their third quarter [...]
Will Crinetics Pharmaceuticals Lead the Healthcare Sector in Performance?
🌥️Trending News Crinetics Pharmaceuticals ($NASDAQ:CRNX) Inc. is a biopharmaceutical company that is focused on discovering and developing new treatments for [...]
CRINETICS PHARMACEUTICALS Reports Positive Financial Results for Second Quarter of FY2023
☀️Earnings Overview CRINETICS PHARMACEUTICALS ($NASDAQ:CRNX) reported total revenue of USD 1.0 million for the second quarter of FY2023, ending on [...]
Insiders Selling Shares Despite No Blame to Crinetics Pharmaceuticals, Shareholders
☀️Trending News Crinetics Pharmaceuticals ($NASDAQ:CRNX), Inc. is a publicly traded biopharmaceutical company that focuses on discovering, developing, and commercializing novel [...]
Crinetics Pharmaceuticals Offers Cutting-Edge Treatment for Acromegaly
Trending News 🌥️ Crinetics Pharmaceuticals ($NASDAQ:CRNX) is a leading biopharmaceutical company specializing in developing innovative treatments for patients with rare [...]
Crinetics Pharmaceuticals Reports Revenues Above Expectations despite Negative GAAP EPS
Trending News ☀️ Crinetics Pharmaceuticals ($NASDAQ:CRNX) recently reported revenue of $2.67M, which exceeded expected numbers by $2.43M. Despite this negative [...]
Crinetics Pharmaceuticals Grants Inducement Awards to Support Nasdaq Listing Rule 5635
Trending News ☀️ Crinetics Pharmaceuticals ($NASDAQ:CRNX), Inc. is a clinical-stage pharmaceutical company that has been dedicated to the discovery, development, [...]
